ReCyte is a regenerative medicine company that focuses on repair of vascular disorders including both age-related diseases and injuries... Read more
ReCyte is a regenerative medicine company that focuses on repair of vascular disorders including both age-related diseases and injuries... Read more
News
Jun 22, 2017
FinSMEs
Recyte Therapeutics: Repare Therapeutics Raises US$68M in Series A Funding
May 06, 2016
BioSpace
Recyte Therapeutics: ReCyte Therapeutics, Inc., A BioTime Subsidiary, Announces Peer-Reviewed Publication On Pericyte-Like Progenitor Cells
Sep 02, 2015
BUSINESS WIRE
Press Release: Recyte Therapeutics : ESI BIO - a Division of BioTime, Inc. Launches New Research Technology Platform, VascuNet Pericyte Co-Culture Assay
Jun 04, 2015
PR-INSIDE.COM
Press Release: Recyte Therapeutics : ReCyte Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - New Study Released